Bayer to shed 4,500 jobs in GermanyBayer on Tuesday told staff that about 4,500 jobs in Germany are to go by the end of 2021, reported on Tuesday FAZ (p19) and Süddeutsche Zeitung (SZ) (p17) and on Wednesday FAZ (p21, 37), SZ (p19), Handelsblatt (p21) and Die Welt (p9) (APMHE 62593).
Merck KGaA raises offer for Versum to $6.5 billionMerck KGaA on Monday raised its offer for U.S. electronic materials Versum Materials to $53-a- share from $48 and won the support of the company's board, reported FAZ (p21, 22) and Handelsblatt (p19) on Tuesday (APMHE 62586).
Fresenius planning acquisitions in 2019German health group Fresenius is planning medium-sized acquisitions in 2019 and bigger deals in 2020 or later, chief finance officer Rachel Empey told FAZ and reported on Tuesday (pp21) (APMHE 62599).
Immunic debuts on Nasdaq after reverse merger with U.S. VitalGerman biotech Immunic Therapeutics, developing drugs to treat chronic inflammatory and autoimmune diseases, is making its debut on the U.S. Nasdaq stock market after a reverse merger with U.S. Vital Therapies, which is already listed, reported Handelsblatt (p16-17) on Tuesday and FAZ on Thursday (p31).
"But our capital requirements are so high that I do not see any chance of financing them in Europe in the medium term."
German biotech growing but on 'shaky basis'The German biotechnology industry is making progress, with turnover up 9% and the number of employees growing by 5% in 2018, but its financing remains on a "shaky basis", according to consultancy firm EY Germany, reported FAZ (p21) and Handelsblatt (p16-17) on Tuesday (p21) (APMHE 62584).
Successful stock market float for AlconNovartis' spin-out Alcon got off to a positive start on the Swiss stock market, Handelsblatt (p33), SZ (p17), Die Welt (p13) and FAZ (p25) reported on Wednesday (APMHE 62597).
New ideas needed in Alzheimer's researchNew ideas in Alzheimer's research are needed after Biogen and Eisai's flop with aducanumab, reported Handelsblatt on Monday (p16-17).
Draft law to support local pharmaciesThe German Health Ministry has drawn up a draft law on "local pharmacies reinforcement", aimed at putting an end to a conflict with the European Commission on German price regulation applied to foreign-based mail order pharmacies (APMHE 62627), SZ (p5) and FAZ (p17) reported on Tuesday (p5).
Ban confirmed on drug vending machineGerman administrative court of Karlsruhe confirmed a ban on a drug vending machine set up by the Dutch mail order pharmacy DocMorris in the village of Hüffenhardt, FAZ said on Saturday (p22).
Three manufacturers licensed to grow medical cannabis in GermanyThree companies have been licensed by German regulator BfArM's Cannabis Agency to grow medical cannabis in Germany: Demecan, joint venture of Canadian Wayland group and a Berlin start-up, and the German subsidiaries of Canadian groups Aphria and Aurora, SZ (p20) reported on Monday and Die Welt (p24) on Friday.
TRY APM HEALTH EUROPE AND GET ACCESS TO THE FULL CONTENT
Interviews with KOLs/senior executives amongst the Regulators, Payers, Health, Medical & Pharmaceutical organisations
Events coverage with a unique focus on Market Access & sustainability of healthcare systems
6 European bureaus : Berlin, Brussels, London, Madrid, Milan & Paris
Ask for a Free trial and get access to the latest stories
- Health Care
- Market Access
- HTA – policies & practices
- European medicine regulations
- Drug safety issues
- Pricing & Reimbursement
- International medicines agencies
If you are a Payer, Pharmaceutical or Consulting professional our premium data will keep you informed on the regulatory, pricing, market access and cost-effectiveness issues that impact all stakeholders.
an initial 10 day temporary access of APM Health Europe.